Bharat Parenterals [BPLPHARMA] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Bharat Parenterals Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bharat Parenterals Ltd. wins in 6 metrics, Gujarat Themis Biosyn Ltd. wins in 13 metrics, with 0 ties. Gujarat Themis Biosyn Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bharat Parenterals Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) -18.20 73.73 Gujarat Themis Biosyn Ltd.
Price-to-Book Ratio 1.90 13.36 Bharat Parenterals Ltd.
Debt-to-Equity Ratio 39.74 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio -0.45 -17.55 Bharat Parenterals Ltd.
EV/EBITDA 11.90 52.76 Bharat Parenterals Ltd.
Profit Margin (TTM) -2.32% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) -10.30% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) N/A 40.16% N/A
Return on Equity -3.72% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) -1.95% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $-563.30M $-251.22M Gujarat Themis Biosyn Ltd.
Dividend Yield 0.08% 0.17% Gujarat Themis Biosyn Ltd.
1-Year Return 10.27% 31.69% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 2.39 22.23 Bharat Parenterals Ltd.
Enterprise Value $4.88B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 1.39 22.65 Bharat Parenterals Ltd.
Gross Profit Margin (TTM) 50.44% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $553 $15 Bharat Parenterals Ltd.
Earnings per Share (Diluted) $-42.80 $4.40 Gujarat Themis Biosyn Ltd.
Beta (Stock Volatility) 0.57 -0.17 Gujarat Themis Biosyn Ltd.

Bharat Parenterals Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

BPLPHARMA
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat Parenterals Ltd.7.15%7.11%11.16%24.46%18.70%15.70%
Gujarat Themis Biosyn Ltd.1.72%-7.03%7.92%39.85%0.71%-8.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat Parenterals Ltd.10.27%274.77%198.94%895.74%895.74%895.74%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Bharat Parenterals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBPLPHARMAGUJTHEM
Market Information
Market Cap i₹8.36B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,92979,452
90 Day Avg. Volume i2,703106,446
Last Close₹1,400.00₹401.80
52 Week Range₹880.25 - ₹1,667.20₹225.05 - ₹479.00
% from 52W High-16.03%-16.12%
All-Time High₹1,870.00 (Dec 02, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-25.13%-16.12%
Growth Metrics
Quarterly Revenue Growth-0.10%0.10%
Quarterly Earnings Growth-0.10%-0.04%
Financial Health
Profit Margin (TTM) i-0.02%0.30%
Operating Margin (TTM) i-0.10%0.40%
Return on Equity (TTM) i-0.04%0.20%
Debt to Equity (MRQ) i39.7427.04
Cash & Liquidity
Book Value per Share (MRQ)₹640.06₹24.29
Cash per Share (MRQ)₹64.78₹0.92
Operating Cash Flow (TTM) i₹-654,312,000₹970.68M
Levered Free Cash Flow (TTM) i₹-126,262,000₹487.72M
Dividends
Last 12-Month Dividend Yield i0.08%0.17%
Last 12-Month Dividend i₹1.00₹0.67

Valuation & Enterprise Metrics Analysis: Bharat Parenterals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBPLPHARMA (Apr 22, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-18.2073.73
Forward P/E iN/AN/A
PEG Ratio i-0.45-17.55
Price to Sales (TTM) i2.3922.23
Price to Book (MRQ) i1.9013.36
Market Capitalization
Market Capitalization i₹8.36B₹35.41B
Enterprise Value i₹4.88B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i1.3922.65
Enterprise to EBITDA i11.9052.76
Risk & Other Metrics
Beta i0.57-0.17
Book Value per Share (MRQ) i₹640.06₹24.29

Financial Statements Comparison: Bharat Parenterals Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBPLPHARMA (2025)GUJTHEM (2025)
Revenue/Sales i3.35B1.51B
Cost of Goods Sold i2.12B318.78M
COGS % of Revenue i63.1%21.1%
Gross Profit i1.24B1.19B
Gross Margin i36.9%78.9%
Research & Development i65.14M34.37M
Operating Income (EBIT) i-308.90M642.49M
Operating Margin i-9.2%42.6%
EBITDA i142.48M713.04M
EBITDA Margin i4.2%47.3%
Pre-Tax Income i-339.51M655.38M
Pre-Tax Income % of Revenue i-10.1%43.5%
Income Tax i97.25M167.66M
Income Tax % of Revenue i2.9%11.1%
Net Income (Profit) i-436.75M487.72M
Profit Margin i-13.0%32.3%

Balance Sheet & Liquidity Metrics

MetricBPLPHARMA (2025)GUJTHEM (2025)
Cash & Equivalents i5.60M116.94M
Total Current Assets i3.56B519.73M
Total Current Assets % of Revenue i106.0%34.5%
Total Current Liabilities i2.19B205.60M
Total Current Liabilities % of Revenue i65.4%13.6%
Long-Term Debt i758.67M296.36M
Long-Term Debt % of Revenue i22.6%19.7%
Total Shareholders Equity i3.39B2.48B
Retained Earnings i1.75B2.37B
Retained Earnings % of Revenue i52.1%157.4%
Property, Plant & Equipment i60.23M411.30M

Cash Flow Statement Comparison

MetricBPLPHARMA (2025)GUJTHEM (2025)
Operating Cash Flow i-654.31M970.68M
Operating Cash Flow % of Revenue i-19.5%64.4%
Capital Expenditures i-286.21M-1.16B
Free Cash Flow i-563.30M-251.22M
FCF Margin i-16.8%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBPLPHARMAGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.89M108.97M
Float Shares i658,94729.52M
% Held by Insiders i79.74%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i20.26%26.84%

Dividend Analysis & Yield Comparison: Bharat Parenterals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricBPLPHARMAGUJTHEM
Last 12-Month Dividend i₹1.00₹0.67
Last 12-Month Dividend Yield i0.08%0.17%
3-Year Avg Annual Dividend i₹0.33₹0.22
3-Year Avg Dividend Yield i0.08%0.17%
3-Year Total Dividends i₹1.00₹0.67
Ex-Dividend DateSep 19, 2025Sep 04, 2025